As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
We review Bayesian and Bayesian decision theoretic approaches to subgroup analysis and applications to subgroup-based adaptive clinical trial designs. Subgroup analysis refers to inference about ...
In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...
However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...
Clinical Trials Arena on MSN
The Bayesian challenge: complexity that pays off
The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.
Marty Makary was appointed commissioner of the Food and Drug Administration (FDA) in 2025. The prominent surgeon, medical researcher, bestselling author, and critic of the medical ...
Machine Learning gets all the marketing hype, but are we overlooking Bayesian Networks? Here's a deeper look at why "Bayes Nets" are underrated - especially when it comes to addressing probability and ...
Approaches for statistical inference -- The Bayes approach -- Bayesian computation -- Model criticism and selection -- The empirical Bayes approach -- Bayesian design -- Special methods and models -- ...
Suggested Citation: "Appendix D: Using Bayes Analysis for Hypothesis Testing." National Academies of Sciences, Engineering, and Medicine. 2019. Reproducibility and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results